Nexalin Technology (NXL) Shares Outstanding (2021 - 2026)
Nexalin Technology (NXL) posted Shares Outstanding (Entity) of $733457.0 for Q2 2026, up 6.91% on a QoQ basis from $686055.0 in Q1 2026, and up 26.33% year-over-year from $580598.0 in Q2 2025.
Analysis
Nexalin Technology (NXL) Shares Outstanding (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $733457.0 in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 26.33% year-over-year to $733457.0 in Q2 2026; TTM through Jun 2026 was $733457.0, a 26.33% increase from a year earlier, with the FY2025 full-year figure at $639545.0, up 108.19% from the prior year.
- Shares Outstanding (Entity) was $733457.0 for Q2 2026 at Nexalin Technology, up from $686055.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $733457.0 in Q2 2026, with the low at $163505.0 in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $366339.3, with a median of $250385.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) rose 2.06% in 2024, then soared 129.59% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $185747.0 in 2022, then soared by 33.45% to $247885.0 in 2023, then rose by 23.93% to $307192.0 in 2024, then jumped by 108.19% to $639545.0 in 2025, then increased by 14.68% to $733457.0 in 2026.
- The last three Shares Outstanding (Entity) figures came in at $733457.0 (Q2 2026), $686055.0 (Q1 2026), and $639545.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 704,764.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 704,764.00 |
| Mar 31, 2026 | 660,697.00 |
| Dec 31, 2025 | 546,416.00 |
| Sep 30, 2025 | 593,128.00 |
| Jun 30, 2025 | 523,938.00 |
| Mar 31, 2025 | 443,577.00 |
| Dec 31, 2024 | 307,192.00 |
| Sep 30, 2024 | 361,583.00 |
| Jun 30, 2024 | 249,918.00 |
| Mar 31, 2024 | 247,885.00 |
| Dec 31, 2023 | 245,234.00 |
| Sep 30, 2023 | 247,179.00 |
| Jun 30, 2023 | 242,885.00 |
| Mar 31, 2023 | 242,885.00 |
| Dec 31, 2022 | 185,747.00 |
| Sep 30, 2022 | 172,890.00 |
| Jun 30, 2022 | 163,224.00 |
| Mar 31, 2022 | 162,936.00 |
| Dec 31, 2021 | 141,879.00 |
| Sep 30, 2021 | 147,452.00 |